Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells in vitro. 2004

Jun-Ming Guo, and Bing-Xiu Xiao, and De-Jian Dai, and Qiong Liu, and Hong-Hui Ma
School of Medicine, Ningbo University, Ningbo 315211, Zhejiang Province, China. junmingguo@yahoo.com

OBJECTIVE To study the effects of daidzein on human pancreatic cancer cells in vitro. METHODS Human estrogen-receptor (ER)-positive pancreatic cancer cells MiaPaCa-2 and ER-negative pancreatic cancer cells PANC-1 were treated by 0.1 micromol/L, 1 micromol/L, 10 microL, 25 microL, 50 microL, 75 microL and 100 microL of daidzein, respectively. Its antiproliferative effect was studied by MTT assay. RESULTS Daidzein inhibited the growth of MiaPaCa-2 and PANC-1 cells at the concentrations from 0.1 microL to 100 microL. A dose- and time-dependent manner was found. The IC(50) of daidzein on MiaPaCa-2 and PANC-1 cells was 45 microL and 75 micro, respectively. After MiaPaCa-2 cells were treated by daidzein for 3 d and at the concentrations more than IC(50), the inhibitory manner was identical and the inhibition appeared a saturation phenomenon, but the inhibitory manner of daidzein on PANC-1 cells was different from that of MiaPaCa-2 cells. CONCLUSIONS Daidzein has antiproliferative effects on human estrogen-receptor-positive and negative pancreatic cancer cells, but their mechanisms may be different.

UI MeSH Term Description Entries
D007529 Isoflavones 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. 3-Benzylchroman-4-One,3-Benzylidene-4-Chromanone,Homoisoflavone,Homoisoflavones,Isoflavone,Isoflavone Derivative,3-Benzylchroman-4-Ones,3-Benzylidene-4-Chromanones,Isoflavone Derivatives,3 Benzylchroman 4 One,3 Benzylchroman 4 Ones,3 Benzylidene 4 Chromanone,3 Benzylidene 4 Chromanones,Derivative, Isoflavone,Derivatives, Isoflavone
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D004968 Estrogens, Non-Steroidal Non-steroidal compounds with estrogenic activity. Estrogens, Nonsteroidal,Estrogens, Non Steroidal,Non-Steroidal Estrogens,Nonsteroidal Estrogens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Jun-Ming Guo, and Bing-Xiu Xiao, and De-Jian Dai, and Qiong Liu, and Hong-Hui Ma
August 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Jun-Ming Guo, and Bing-Xiu Xiao, and De-Jian Dai, and Qiong Liu, and Hong-Hui Ma
December 2010, Cell cycle (Georgetown, Tex.),
Jun-Ming Guo, and Bing-Xiu Xiao, and De-Jian Dai, and Qiong Liu, and Hong-Hui Ma
December 1982, Cancer research,
Jun-Ming Guo, and Bing-Xiu Xiao, and De-Jian Dai, and Qiong Liu, and Hong-Hui Ma
January 1990, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
Jun-Ming Guo, and Bing-Xiu Xiao, and De-Jian Dai, and Qiong Liu, and Hong-Hui Ma
March 1995, Journal of the National Cancer Institute,
Jun-Ming Guo, and Bing-Xiu Xiao, and De-Jian Dai, and Qiong Liu, and Hong-Hui Ma
January 1994, Anticancer research,
Jun-Ming Guo, and Bing-Xiu Xiao, and De-Jian Dai, and Qiong Liu, and Hong-Hui Ma
August 1989, Cancer,
Jun-Ming Guo, and Bing-Xiu Xiao, and De-Jian Dai, and Qiong Liu, and Hong-Hui Ma
February 1993, Molecular and cellular endocrinology,
Jun-Ming Guo, and Bing-Xiu Xiao, and De-Jian Dai, and Qiong Liu, and Hong-Hui Ma
January 2015, PloS one,
Copied contents to your clipboard!